00512 遠大醫藥
按盤價 
4.750 +0.010 (+0.211%) | 2023/12 - 末期 港元(千$) | 2022/12 港元(千$) | 2021/12 港元(千$) | 2020/12 港元(千$) | 2019/12 港元(千$) | |
| 經營活動之現金流量 | 2,424,895 | 1,842,676 | 2,005,675 | 1,455,946 | 1,303,945 |
| 投資活動之現金流量 | (515,747) | (2,360,106) | (1,768,979) | (1,513,163) | (443,579) |
| 融資活動之現金流量 | (1,889,399) | 327,000 | (333,171) | 774,269 | (710,200) |
| 現金及等同現金之增加/(減少) | 19,749 | (190,430) | (96,475) | 717,052 | 150,166 |
| 期初之現金及現金等價物 | 1,444,014 | 1,752,860 | 1,836,695 | 1,059,269 | 912,244 |
| 匯率變動之影響 | (124,055) | (118,416) | 12,640 | 60,374 | (3,141) |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 期末之現金及現金等價物 | 1,339,708 | 1,444,014 | 1,752,860 | 1,836,695 | 1,059,269 |
| 股東應佔溢利/(虧損) (千) | HKD 1,557,945 |
| 增長率 | 51.352% |
| 每股盈利/(虧損) | HKD 0.444 |
| 每股帳面資產淨值 ($) | HKD 4.428 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
